Atlas Trials

BCX-1777 in Treating Patients With Refractory Cancer

Clinical trial NCT00073944 · COMPLETED

Trial details

NCT number
NCT00073944
Sponsor
BioCryst Pharmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cancer
Start date
2003-04-01
Primary completion
2005-01-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.